This content is machine translated Liver Cancer Artificial Intelligence in Precision Oncology—Opportunities and Challenges The 2025 ESMO Congress covered a wide range of translational and clinical topics, with the growing importance of artificial intelligence (AI) in diagnosis, prognosis, and treatment decisions standing out in...…
View Post 2 min This content is machine translated Organ Donation New hope: peak in organ donations in 2023 Last year, 200 people became organ donors after their death, more than ever before. The number of people who received an organ also reached an all-time high: 675 people received…
View Post 3 min This content is machine translated Biomarkers and prognostic factors Kidneys, liver, intestines and co. put to the test The ESMO Congress is the largest European cross-indication cancer congress. It serves to improve the quality of cancer treatment, cancer prevention and diagnosis as well as palliative care and aftercare…
View Post 5 min This content is machine translated Local therapy in HCC Interdisciplinary combination therapies on the rise Small changes made in the 2022 BCLC update may be of great impact in the local therapy of stage 0 to C HCC patients. Combination therapies and other interdisciplinary measures…
View Post 2 min This content is machine translated Cancer Prevention Do statins protect against liver cancer? Several studies have shown that statin therapy reduces the risk of liver cancer. However, most of these papers come from countries with high incidence of liver cancer (Asian region). Now…
View Post 8 min This content is machine translated Hepatocellular carcinoma When is liver transplantation a reasonable treatment option? When patients with hepatocellular carcinoma (HCC) meet certain criteria for tumor size, tumor number, and metastasis, liver transplantation may be a reasonable treatment option. The allocation of available organs is…
